• CJC‑1295 (no DAC) - NuroCore
  • CJC‑1295 (no DAC) - NuroCore
  • CJC‑1295 (no DAC) - NuroCore
1 3

NuroCore

CJC‑1295 (no DAC)

CJC‑1295 (no DAC)

350.00 AED
350.00 AED
Sale Sold out
Shipping calculated at checkout.
Size

CJC-1295 (No DAC), also known as Mod GRF 1-29, is a synthetic growth hormone releasing hormone (GHRH) analog without the Drug Affinity Complex. It is studied for short-acting GH release, pulsatile secretion, and metabolic research. Within NuroCore, it is categorized under Growth & Metabolic Research.

View full details


Concentration: Commonly 2 mg or 5 mg vials (lyophilized powder)

Composition: Synthetic GHRH analog (29 amino acids, stabilized variant)

Formulation: Lyophilized acetate salt

Half-Life: ~30 minutes plasma

Primary Actions: Pulsatile GH release, IGF-1 axis, metabolic studies

Studied for enhancing natural GH pulses in experimental models.

Explored for metabolic, recovery, and regenerative research.

Often combined with GHRPs (Ipamorelin, GHRP-2, GHRP-6) for synergy.

Distinguished from DAC version by short-acting profile.

Reconstitute with bacteriostatic water (NuroCore standard).

Swirl gently until dissolved.

Handle under sterile research conditions.


Unreconstituted: Store at –20 °C.

Reconstituted: Refrigerate at 2–8 °C.

Appearance: Clear, colorless solution; discard if cloudy or particulate.

Category: Growth & Metabolic Research (NuroCore)

Use Case: Research into short-acting GH release and pulsatile secretion

Compliance Note: Classified strictly as a research compound

Other customers also bought

View all